A Courtois Selected Research

Breast Neoplasms (Breast Cancer)

10/2021

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Courtois Research Topics

Disease

2	Cholestasis 01/2024 - 11/2000
2	Inflammation (Inflammations) 01/2014 - 01/2001
2	Carcinogenesis 01/2001 - 11/2000
1	Thrombocytosis (Thrombocythemia) 01/2024
1	Hypoalbuminemia 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Neoplasms (Cancer) 10/2021
1	Vascular Diseases (Vascular Disease) 12/2017
1	Pain (Aches) 04/2017
1	Type 2 Diabetes Mellitus (MODY) 02/2001
1	Lung Neoplasms (Lung Cancer) 02/2001
1	Acute-Phase Reaction 01/2001

Drug/Important Bio-Agent (IBA)

2	Hormones (Hormone)IBA 10/2021 - 11/2000
2	XenobioticsIBA 01/2001 - 11/2000
1	Estrogens (Estrogen)FDA Link 10/2021
1	Letrozole (Femara)FDA LinkGeneric 10/2021
1	CalciumIBA 12/2017
1	ElementsIBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	multidrug resistance-associated protein 1IBA 02/2001
1	Glyburide (Glibenclamide)FDA LinkGeneric 02/2001
1	Proteins (Proteins, Gene)FDA Link 02/2001
1	Adenosine Triphosphate (ATP)IBA 02/2001
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 02/2001
1	EndotoxinsIBA 01/2001
1	EnzymesIBA 01/2001
1	oltiprazIBA 01/2001

Therapy/Procedure

1	Immunotherapy 01/2024
1	Conservative Treatment 04/2017
1	Aftercare (After-Treatment) 11/2000